Shandong Sinobioway Biomedicine Co., Ltd. (002581.SZ)

CNY 12.4

(-0.08%)

Market Cap (In CNY)

8.18 Billion

Revenue (In CNY)

429.79 Million

Net Income (In CNY)

-332.45 Million

Avg. Volume

3.45 Million

Currency
CNY
Country
Basic Materials
Open
-
Prev. Close
-
Day Range
-
Year Range
7.79-14.81
PE
-
EPS
-
Beta Value
0.08
ISIN
CNE1000012Y5
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Mr. Jialin Yue
Employee Count
-
Website
https://www.sdsinobioway.com
Ipo Date
2011-05-20
Details
Shandong Sinobioway Biomedicine Co., Ltd. manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, nerve growth factor, and alfaron in China. The company also provides NOBEX, a murine nerve growth factor for injection; Anferon, a human recombinant interferon alpha 2b injection; and Jaferon, a human recombinant interferon alpha 2b spray. In addition, it offers Healive, an inactivated hepatitis A vaccine; Bilive, a combined hepatitis A and B Vaccine; Panflu, a pandemic influenza vaccine; Anflu, a preservative-free influenza virus vaccine; Panflu.1, a Type A H1N1 influenza vaccine; etc. Further, the company exports its products to approximately 20 counties and regions in Europe and the United States. Shandong Sinobioway Biomedicine Co., Ltd. was founded in 2000 and is headquartered in Zibo, China.